Increasing Awareness About Advanced Embolic Protection Devices and Favorable Reimbursement Policies to Stimulate the Growth of the Embolic Protection Devices Market in the US

Published: May 2021

The US embolic protection devices market is estimated to exhibit a substantial CAGR of 8.3% during the forecast period (2021-2027). Due to the rising patient pool in the country, there has been a significant increase in the number of surgical procedures performed for treating heart diseases. For instance, the Agency of Healthcare Research and Quality reported, approximately 41,025 TAVR procedures were performed in the US between 2016-2018. Such a rising number leads to a greater number of embolic complications, which further enhances the uptake of embolic protection devices in the country.

Browse the full report description of "US Embolic Protection Devices Market Size, Share & Trends Analysis Report by Product (Filter Devices and Occlusion Devices), by Application (Cardiovascular & Peripheral and Neurovascular), and by End-user (Ambulatory Surgery Centers, Freestanding CATH Labs, Hospitals, and Specialty Cardiac Centers) Forecast Period (2021-2027)" at https://www.omrglobal.com/industry-reports/us-embolic-protection-devices-market

As the treatment-seeking population is also notably higher in this country than in developing countries, the adoption of EPDs is also higher in the US. Moreover, the market in the US is expected to grow during the forecast period owing to the increasing demand for advanced devices, especially embolic protection devices indicated for the TAVR procedure. In addition, the rising aging population in the country is at a higher risk of developing various cardiac disorders. In 2017, around 16% of the population was 65 years old or more, which is expected to reach around 22% by 2050. Therefore, the embolic protection devices market in the US is expected to grow steadily during the forecast period owing to the growing elderly population, increasing awareness about advanced embolic protection devices, and favorable reimbursement policies.

Market Coverage

  • Market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segments Covered- by Product, Application, and End-user
  • Country Covered- US
  • Competitive Landscape- Abbott; Boston Scientific Corp.; Cardinal Health, Inc.; and Medtronic plc

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment dominates the market in base year?
  • Which segment will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

US Embolic Protection Devices Market Report Segment

By Product 

  • Filter Devices
  • Occlusion Devices

By Application

  • Cardiovascular & Peripheral
  • Neurovascular

By End-user

  • Ambulatory Surgery Centers
  • Freestanding CATH Labs
  • Hospitals
  • Specialty Cardiac Centers

To learn more about this report request a sample copy @  https://www.omrglobal.com/request-sample/us-embolic-protection-devices-market